[go: up one dir, main page]

WO2008133196A1 - Material for regenerative medicine - Google Patents

Material for regenerative medicine Download PDF

Info

Publication number
WO2008133196A1
WO2008133196A1 PCT/JP2008/057574 JP2008057574W WO2008133196A1 WO 2008133196 A1 WO2008133196 A1 WO 2008133196A1 JP 2008057574 W JP2008057574 W JP 2008057574W WO 2008133196 A1 WO2008133196 A1 WO 2008133196A1
Authority
WO
WIPO (PCT)
Prior art keywords
regenerative medicine
matrix
genetically modified
modified gelatin
disclosed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2008/057574
Other languages
French (fr)
Japanese (ja)
Inventor
Shouji Ooya
Takayuki Kobayashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujifilm Corp
Original Assignee
Fujifilm Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujifilm Corp filed Critical Fujifilm Corp
Publication of WO2008133196A1 publication Critical patent/WO2008133196A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/222—Gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Transplantation (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Disclosed is a material for regenerative medicine, which enables to reduce the risk of causing an infection in a collagen-like peptide, and to precisely design parameters required for a matrix for regenerative medicine. Specifically disclosed is a material for regenerative medicine, which comprises a genetically modified gelatin. The genetically modified gelatin is contacted with a biological tissue as a matrix.
PCT/JP2008/057574 2007-04-19 2008-04-18 Material for regenerative medicine Ceased WO2008133196A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007-110041 2007-04-19
JP2007110041 2007-04-19

Publications (1)

Publication Number Publication Date
WO2008133196A1 true WO2008133196A1 (en) 2008-11-06

Family

ID=39925650

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/057574 Ceased WO2008133196A1 (en) 2007-04-19 2008-04-18 Material for regenerative medicine

Country Status (1)

Country Link
WO (1) WO2008133196A1 (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010128672A1 (en) * 2009-05-07 2010-11-11 富士フイルム株式会社 Neovascularization inducer comprising genetically recombined gelatin
WO2011027850A1 (en) * 2009-09-04 2011-03-10 富士フイルム株式会社 Bone regeneration agent including gelatin
JP2012219100A (en) * 2011-04-12 2012-11-12 Fujifilm Corp Composition containing cell and biocompatible polymer
CN102791301A (en) * 2010-03-02 2012-11-21 富士胶片株式会社 Cell-supporting body and bone regeneration material
JP2013074936A (en) * 2011-09-29 2013-04-25 Fujifilm Corp Scaffold for vascular endothelial cell migration
JP2014012114A (en) * 2011-08-31 2014-01-23 Fujifilm Corp Cell structure for cell transplantation and cell aggregate for cell transplantation
WO2014050908A1 (en) 2012-09-26 2014-04-03 富士フイルム株式会社 Polypeptide, scaffold composition, composition for cartilage tissue restoration, composition for cartilage cell culture, and composition for promoting glycosaminoglycan production
JP2016174538A (en) * 2015-03-18 2016-10-06 富士フイルム株式会社 Tubular structure, method for producing cell structure, and method for producing tubular structure
CN111704663A (en) * 2020-06-29 2020-09-25 江南大学 A kind of preparation method of collagen hydrogel
CN111793127A (en) * 2020-06-17 2020-10-20 江南大学 A type III human collagen and its encoding gene, recombinant bacteria and application
CN112661856A (en) * 2020-08-20 2021-04-16 点斗基因科技(南京)有限公司 Purification method and application of ELP collagen

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03502935A (en) * 1988-11-09 1991-07-04 プロテイン　ポリマー　テクノロジーズ，インコーポレイティド Recombinantly prepared functional synthetic protein polymers
JP2001502548A (en) * 1996-10-29 2001-02-27 コモンウェルス サイエンティフィック アンド アンダストリアル リサーチ オーガニゼーション Stable expression of triple helix protein
JP2003516730A (en) * 1999-11-12 2003-05-20 ファイブローゲン、インコーポレーテッド Recombinant gelatin
WO2004085473A2 (en) * 2003-03-28 2004-10-07 Fuji Photo Film B.V. Rgd-enriched gelatine-like proteins with enhanced cell binding
JP2007277217A (en) * 2006-03-17 2007-10-25 Fujifilm Corp Biodegradable matrix encapsulating drug uniformly

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03502935A (en) * 1988-11-09 1991-07-04 プロテイン　ポリマー　テクノロジーズ，インコーポレイティド Recombinantly prepared functional synthetic protein polymers
JP2001502548A (en) * 1996-10-29 2001-02-27 コモンウェルス サイエンティフィック アンド アンダストリアル リサーチ オーガニゼーション Stable expression of triple helix protein
JP2003516730A (en) * 1999-11-12 2003-05-20 ファイブローゲン、インコーポレーテッド Recombinant gelatin
WO2004085473A2 (en) * 2003-03-28 2004-10-07 Fuji Photo Film B.V. Rgd-enriched gelatine-like proteins with enhanced cell binding
JP2007277217A (en) * 2006-03-17 2007-10-25 Fujifilm Corp Biodegradable matrix encapsulating drug uniformly

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5752033B2 (en) * 2009-05-07 2015-07-22 富士フイルム株式会社 Angiogenesis inducer containing genetically modified gelatin
WO2010128672A1 (en) * 2009-05-07 2010-11-11 富士フイルム株式会社 Neovascularization inducer comprising genetically recombined gelatin
US9968661B2 (en) 2009-09-04 2018-05-15 Fujifilm Corporation Bone regeneration agent including gelatin
WO2011027850A1 (en) * 2009-09-04 2011-03-10 富士フイルム株式会社 Bone regeneration agent including gelatin
CN102625717A (en) * 2009-09-04 2012-08-01 富士胶片株式会社 Bone regeneration agent containing gelatin
US8987204B2 (en) 2009-09-04 2015-03-24 Fujifilm Coporation Bone regeneration agent comprising gelatin
CN102625717B (en) * 2009-09-04 2016-03-16 富士胶片株式会社 Bone regeneration agent containing gelatin
JP2015033635A (en) * 2009-09-04 2015-02-19 富士フイルム株式会社 Granulation tissue forming agent containing genetically modified gelatin
JP5642685B2 (en) * 2009-09-04 2014-12-17 富士フイルム株式会社 Bone regenerant containing gelatin
US9101686B2 (en) 2010-03-02 2015-08-11 Fujifilm Corporation Cell support and bone regeneration material
CN102791301A (en) * 2010-03-02 2012-11-21 富士胶片株式会社 Cell-supporting body and bone regeneration material
JP2012219100A (en) * 2011-04-12 2012-11-12 Fujifilm Corp Composition containing cell and biocompatible polymer
JP2016188235A (en) * 2011-04-12 2016-11-04 富士フイルム株式会社 Composition comprising cells and biocompatible polymer
US10406183B2 (en) 2011-04-12 2019-09-10 Fujifilm Corporation Composition comprising cell and biocompatible polymer
JP2014012114A (en) * 2011-08-31 2014-01-23 Fujifilm Corp Cell structure for cell transplantation and cell aggregate for cell transplantation
JP2013074936A (en) * 2011-09-29 2013-04-25 Fujifilm Corp Scaffold for vascular endothelial cell migration
EP2578246A3 (en) * 2011-09-29 2015-01-14 Fujifilm Corporation Scaffold for vascular endothelial cell migration
US9932557B2 (en) 2012-09-26 2018-04-03 Fujifilm Corporation Polypeptide, scaffold composition, composition for cartilage tissue restoration, composition for cartilage cell culture, and composition for promoting glycosaminoglycan production
WO2014050908A1 (en) 2012-09-26 2014-04-03 富士フイルム株式会社 Polypeptide, scaffold composition, composition for cartilage tissue restoration, composition for cartilage cell culture, and composition for promoting glycosaminoglycan production
JP2016174538A (en) * 2015-03-18 2016-10-06 富士フイルム株式会社 Tubular structure, method for producing cell structure, and method for producing tubular structure
CN111793127A (en) * 2020-06-17 2020-10-20 江南大学 A type III human collagen and its encoding gene, recombinant bacteria and application
CN111793127B (en) * 2020-06-17 2021-11-02 江南大学 A type III human collagen and its encoding gene, recombinant bacteria and application
CN111704663A (en) * 2020-06-29 2020-09-25 江南大学 A kind of preparation method of collagen hydrogel
CN112661856A (en) * 2020-08-20 2021-04-16 点斗基因科技(南京)有限公司 Purification method and application of ELP collagen

Similar Documents

Publication Publication Date Title
WO2008133196A1 (en) Material for regenerative medicine
WO2008006895A3 (en) Methods and compositions for increasing the efficiency of therapeutic antibodies using gamma delta t cell activators
ES2422739T3 (en) Composition for the diagnosis, prevention or treatment of diseases related to cells expressing IL-8 or GRO-, comprising UCB MSC
EP2102927A4 (en) HEART-SKIN SPINEL ACTIVE CATHODE MATERIAL FOR USE IN LITHIUM SECONDARY BATTERIES, SECONDARY BATTERIES COMPRISING SAME, AND PREPARATION METHOD THEREOF
BRPI0906549A2 (en) Medical bandages with valves and kits containing them.
WO2008103041A8 (en) Recombinant gelatins
WO2010008739A3 (en) Aryl gpr119 agonists and uses thereof
WO2007137072A3 (en) Assays for diagnosing and evaluating treatment options for fabry disease
UA108598C2 (en) HIGH-EFFICIENT CONJUGATES AND HYDROPHILIC STAPLING AGENTS (LINERS)
PL2214562T3 (en) Surgical instrument for sealing blood vessels, and heat-curable adhesive as a medicament
SG196838A1 (en) Gpr120 receptor agonists and uses thereof
FR2903702B1 (en) EQUIVALENT OF EPIDERM CAPABLE OF PIGMENTING OBTAINED FROM CELLS OF THE MATRIX, PROCESS FOR THEIR PREPARATION AND USE
BRPI0811648A2 (en) CATHETER FOR ADMINISTERING AN AGENT FROM A FAMILY SUPPLIER FOR A MAMMALIAN ORGANISM AND METHODS FOR ADMINISTERING A FABRIC FOR A TARGET MATERIAL AND A ADMINISTRATOR FOR A MAMMALIAN ORGANISM FOR TARGET FABRIC ARRANGED BEYOND INTERMEDIATE FABRIC OF A MAMMALIAN ORGANISM
BRPI0819649A2 (en) method, genetically modified organism, and recombinant yeast cell
NZ593365A (en) Pharmaceutical preparation comprising a blood mononuclear cell culture
BR112012031626A2 (en) pressure sensitive adhesive composition for skin application, layered adhesive construction, and medical device
WO2009114712A3 (en) Assays for diagnosing and evaluating treatment options for pompe disease
WO2013056049A3 (en) Tubular prostheses
WO2012050896A3 (en) Protease selective supramolecular assemblies
USD548176S1 (en) Battery module
WO2007109733A3 (en) Diagnostic and prognostic markers and treatment strategies for multiple sclerosis
WO2006104866A3 (en) Controlled adhesion glove
WO2007019865A3 (en) Therapy with cd4 binding peptides and radiation
NZ601735A (en) Antibody with binding specificity for Nedd4 protein for reducing influenza infectivity
IL203762A (en) Use of a composition comprising collagen for the cultivation of biological cells

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08740629

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08740629

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP